Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs being announced each month. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

VIA Pharmaceuticals hired Rebecca Taub as senior vp of R&D;
Roche named Steve Sembler as vp of US commercial operations;
Enzo Biochem named Christine Fischette as prez of its therapeutics subsidiary;
BioCryst Pharma hired Thomas Simon as interim chief medical officer;
Mersana named John van Duzer as vp of manufacturing and pharmaceutical sciences;
Nastech named Bruce York as interim chief financial officer;
Pearl appointed Colin Reisner chief medical officer and executive vp, clinical development;
Pearl named Michael Golden vp, regulatory affairs and quality;
Intercept named Luciano Adorini chief scientific officer;
Chimerix appointed Neil Frazer chief medical officer;
NPS named Alan Harris chief medical officer;
The Structural Genomics Consortium named Chas Bountra, formerly of Glaxo, as chief scientist;
Patrick Ronan, a former FDA chief of staff under FDA commish Andy von Eschenbach, resigned from Novartis Pharmaceuticals where he was vp regulatory policy & external affairs.